KYNTRA BIO, INC.

KYNB · Nasdaq · SIC 2834: Pharmaceutical Preparations
218
SEC Filings

Business Summary

5 Item 1A. Risk Factors 20 Item 1B. Unresolved Staff Comments 49 Item 1C Cybersecurity 49 Item 2. Properties 50 Item 3. Legal Proceedings 51 Item 4. Mine Safety Disclosures 51 PART II 52 Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 52 Item 6. [Reserved] 52 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 53 Item 7A. Quantitative and Qualitative Disclosure About Market Risks 67 Item ...

Next Earnings

Q2 FY2026 — expected 2026-09-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionKYNBdiscussed_in_filing Cybersecurity
topic_mentionKYNBdiscussed_in_filing Cybersecurity
topic_mentionKYNBdiscussed_in_filing Cybersecurity
topic_mentionKYNBdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-162025-12-310001193125-26-108346EDGAR80K words
2025-03-172024-12-310000950170-25-040280EDGAR—
2024-02-262023-12-310000950170-24-020161EDGAR—
2023-02-272022-12-310000950170-23-004668EDGAR—
2022-02-282021-12-310001564590-22-007632EDGAR—
2021-03-012020-12-310001564590-21-009871EDGAR—
2020-03-022019-12-310001564590-20-008161EDGAR—
2019-02-272018-12-310001564590-19-004979EDGAR—
2018-02-272017-12-310001564590-18-003508EDGAR—
2017-03-012016-12-310001564590-17-003095EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001193125-25-274241EDGAR53K words
2025-08-112025-06-300000950170-25-106549EDGAR—
2025-05-122025-03-310000950170-25-069203EDGAR—
2024-11-122024-09-300000950170-24-125388EDGAR—
2024-08-062024-06-300000950170-24-091808EDGAR—
2024-05-062024-03-310000950170-24-053554EDGAR—
2023-11-062023-09-300000950170-23-059394EDGAR—
2023-08-072023-06-300000950170-23-039070EDGAR—
2023-05-082023-03-310000950170-23-018814EDGAR—
2022-11-072022-09-300000950170-22-022605EDGAR—
2022-08-082022-06-300000950170-22-015530EDGAR—
2022-05-092022-03-310000950170-22-008573EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-160001193125-26-108324EDGAR3K words
2026-01-070001193125-26-006327EDGAR—
2025-11-100001193125-25-274192EDGAR—
2025-11-060001193125-25-269529EDGAR—
2025-09-050000921299-25-000007EDGAR—
2025-09-020000950170-25-112341EDGAR—
2025-08-180000950170-25-109571EDGAR—
2025-08-140000950170-25-108280EDGAR—
2025-08-110000950170-25-106534EDGAR—
2025-07-140000950170-25-095628EDGAR—

218 total filings indexed. 186 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0000921299
TickerKYNB
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c06bb405a7a1f62bcfeb47ce015f8a895f1a3494c0898fa051c9b557151adc12
parent: 5a2f374ab641860faec7276faa8f74acc2841335905569bc5a619c102589159b
content hash: dabd2f41264039ae7cf7dcdfd7862f864a537d224c7d724a205361518a20bf94
signed: 2026-04-13T04:45:57.544Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf